Phoenix Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-3,630
Closed -$1.33M – 316
2022
Q4
$1.33M Buy
+3,630
New +$1.29M 0.03% 163

Other funds holding LLY

Phoenix Financial's LLY Position: Q3 2026 in Review

Phoenix Financial increased its Eli Lilly (LLY) stake by 0.3% in Q3 2026, buying an estimated $339K and bringing the position to 97,306 shares worth $105M. The position accounts for 0.71% of the portfolio, ranked #37.

Phoenix Financial first reported a position in LLY in Q2 2022 and has held it in 18 quarters since. The position peaked at $116M in Q2 2026. 4,599 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Phoenix Financial held 97,306 shares of Eli Lilly worth $105M as of Q3 2026.
  • Phoenix Financial bought 287 Eli Lilly shares in Q3 2026, an estimated $339K.
  • Eli Lilly made up 0.71% of Phoenix Financial's portfolio in Q3 2026, its #37 holding.
  • Phoenix Financial first reported a position in Eli Lilly in Q2 2022 and has held it in 18 quarters since.
  • Phoenix Financial's Eli Lilly position peaked at $116M in Q2 2026.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Phoenix Financial's 13F filing for Q3 2026, filed 9 Nov 2026.